Results 251 to 260 of about 859,419 (358)
Pterostilbene (Pte) binds to the VP1 hydrophobic pocket of enteroviruses, stabilizing the viral capsid and preventing uncoating and RNA release. In vitro, Pte inactivates virions and impairs viral attachment, entry, and replication. In vivo, oral administration of Pte in hSCARB2‐transgenic mice reduces clinical symptoms and improves survival ...
Kuan‐Ting Chuang+9 more
wiley +1 more source
Abstract Background The SARS‐COV‐2 (Covid‐19) pandemic has impacted the management of patients with hematologic disorders. In some entities, an increased risk for Covid‐19 infections was reported, whereas others including chronic myeloid leukemia (CML) had a lower mortality.
Irene Graf+7 more
wiley +1 more source
Global production capacity of seasonal and pandemic influenza vaccines in 2023. [PDF]
Taaffe J+3 more
europepmc +1 more source
Recent multi‐omics studies have demonstrated that belimumab specifically targets naïve B cells and a subset of memory B cells. This observation is consistent with belimumab's established efficacy and safety profile. Abstract Belimumab is an antibody targeting the cytokine B‐cell activating factor (BAFF), which is crucial for B cell differentiation, and
Keishi Fujio+5 more
wiley +1 more source
Dual decision-making routes for COVID-19 and influenza vaccines uptake in parents: A mixed-methods study. [PDF]
Yuan J, Dong M, Ip DKM, So HC, Liao Q.
europepmc +1 more source
Abstract This study aims to identify different frontline emergency response workforce's perceived knowledge of hazards and their willingness and motivations to go to work during them. An online version of the “Fight or Flight” survey was distributed and collected from Norwegian emergency personnel during the spring of 2023.
Jarle L. Sørensen+9 more
wiley +1 more source
Our retrospective study analyzed 40 patients with intensive care unit (ICU)‐dependent autoimmune encephalitis (AE) for clinical characteristics, diagnostics, prognostic factors, and clinical outcomes regarding standard treatment in responsive patients versus additional escalation therapies for treatment‐refractory cases.
Lisa Schwarz+4 more
wiley +1 more source